NCT00447798

Brief Summary

The proposed study uses a two-arm randomized experimental design to evaluate the efficacy of a brief, theoretically-guided, "Prevention Care Advocate" intervention with HIV-positive crack users. Study participants will be recruited from the HIV inpatient hospital wards of two inner-city hospitals that serve a similar population of HIV-positive patients: Jackson Memorial Hospital (JMH) in Miami, Florida and Grady Memorial Hospital (GMH) in Atlanta, Georgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
413

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Timeline
Completed

Started Jun 2005

Longer than P75 for not_applicable hiv-infections

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2005

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 13, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 15, 2007

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

April 1, 2015

Status Verified

March 1, 2015

Enrollment Period

5.8 years

First QC Date

March 13, 2007

Last Update Submit

March 31, 2015

Conditions

Keywords

HIV positivecrack cocaine userinpatient hospital settingHIV knowledgemotivationperceived self-efficacyrisky sexual behaviorHIV seronegativity

Outcome Measures

Primary Outcomes (1)

  • To evaluate the efficacy of a brief, theoretically-based intervention in reducing unprotected sexual intercourse by HIV-positive crack users recruited from the inpatient/hospital setting.

    1 year

Secondary Outcomes (1)

  • The impact of the intervention on secondary outcomes including the increased use of HIV primary outpatient care and readiness for and entry to drug treatment, will also be evaluated.

    1 year

Study Arms (2)

Prevention Care Advocate

EXPERIMENTAL

Prevention Care Advocate (PCA) intervention contains elements based on cognitive-behavioral theories and strengths-based case management. Intervention arm participants will undergo an 8 session intervention comprised of three components: 1) An individual strengths-based case management approach aimed at motivating participants to seek or maintain their engagement with HIV primary care and drug treatment; 2) A cognitive-behavioral, skills-building approach to increase participants' risk reduction knowledge, skills, and perceived self-efficacy as well as intention to change high risk transmission behaviors; and 3) A community placement in which study participants will have the opportunity to practice their advocacy skills in prevention and care setting.

Behavioral: Prevention Care Advocate

Standard of Care

NO INTERVENTION

Standard of Care (SOC) condition involves standard practice, consisting of usual inpatient/hospital services provided within normal clinical practice, plus a brief educational session consisting of the review of the topics in the "Living with HIV" brochure published by the Centers for Disease Control and Prevention (CDC).

Interventions

Prevention Care Advocate: 8 Session intervention combining cognitive-behavioral skill building \& strengths based case management

Prevention Care Advocate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV positive
  • Sexually active
  • Recruited from inpatient/hospital setting
  • Crack user

You may not qualify if:

  • HIV negative
  • Not sexually active
  • Not recruited from inpatient/hospital setting
  • Non crack user

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Miami Hospital & Clinics/ Jackson Memorial Hospital

Miami, Florida, 33136, United States

Location

Grady Health System-Grady Memorial Hospital

Atlanta, Georgia, 30303, United States

Location

MeSH Terms

Conditions

HIV InfectionsHIV Seropositivity

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Lisa R Metsch, Ph.D.

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Carlos del Rio, M.D.

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Stephen Smith Professor of Sociomedical Sciences and Chair, Department of Sociomedical Sciences

Study Record Dates

First Submitted

March 13, 2007

First Posted

March 15, 2007

Study Start

June 1, 2005

Primary Completion

March 1, 2011

Study Completion

May 1, 2011

Last Updated

April 1, 2015

Record last verified: 2015-03

Locations